DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR VITAMIN A PALMITATE

« Back to Dashboard

Clinical Trials for Vitamin A Palmitate

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00000116	Randomized Trial for Retinitis Pigmentosa	Completed	National Eye Institute (NEI)	Phase 3	The purpose of this trial is to determine whether a nutritional supplement in addition to vitamin A will slow the course of retinitis pigmentosa.
NCT00001972	PET Scan of Brain Metabolism in Relation to Age and Disease	Completed	National Institute of Neurological Disorders and Stroke (NINDS)	N/A	The main source of energy for the brain comes from a combination of oxygen and glucose (sugar). For brain cells to function normally they must receive a constant supply of these nutrients. As areas of the brain become more active blood flow into and out of these areas increase. In addition to oxygen and glucose, the brain uses chemical compounds known as phospholipids. These phospholipids make up the covering of nerve cells that assist in the transfer of information from cell to cell. Without phospholipids brain cell activity may become abnormal and cause problems in the nervous system. Certain diseases like Alzheimer's disease and brain tumors can affect blood flow to the brain and change the way the brain metabolizes phospholipids. In addition to diseases, changes in the brain occur with normal healthy aging. This study is designed to use PET scan to measure changes in blood flow and changes in phospholipid metabolism. Using this technique, researchers can improve their understanding of how certain diseases change the shape and function of the brain.
NCT00063596	Vitamin A Supplementation in Preterm Infants	Unknown status	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	N/A	Extremely low birth weight infants have decreased blood levels of Vitamin A. This Vitamin A deficiency may increase the risk of infections and chronic lung disease in these infants. This study will examine the effects of Vitamin A supplementation in premature babies born weighing less than 1500 grams (3.3 lbs).

Clinical Trial Conditions for Vitamin A Palmitate

Condition Name

Condition Name for Vitamin A Palmitate
Intervention	Trials
Schizophrenia	47
Insulin Resistance	4
Retinitis Pigmentosa	3

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Vitamin A Palmitate
Intervention	Trials
Schizophrenia	49
Insulin Resistance	5
Diabetes Mellitus, Type 2	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Vitamin A Palmitate

Trials by Country

Trials by Country for Vitamin A Palmitate
Location	Trials
United States	247
Korea, Republic of	16
Canada	13
Taiwan	11
Ukraine	9

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Vitamin A Palmitate
Location	Trials
California	20
Texas	19
Missouri	13
New York	13
Ohio	12

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Vitamin A Palmitate

Clinical Trial Phase

Clinical Trial Phase for Vitamin A Palmitate
Clinical Trial Phase	Trials
Phase 4	26
Phase 3	27
Phase 2/Phase 3	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Vitamin A Palmitate
Clinical Trial Phase	Trials
Completed	58
Recruiting	12
Not yet recruiting	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Vitamin A Palmitate

Sponsor Name

Sponsor Name for Vitamin A Palmitate
Sponsor	Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	11
Janssen Scientific Affairs, LLC	6
Tehran University of Medical Sciences	5

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Vitamin A Palmitate
Sponsor	Trials
Other	70
Industry	50
NIH	15

Export unavailable in trial.
Subscribe for complete access.